A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines

Haematologica

Volumn 92, Issue 7, 2007, Pages 913-920

  Feys, Tom ^a   Poppe, Bruce ^a   De Preter, Katleen ^a   Van Roy, Nadine ^a   Verhasselt, Bruno ^a   De Paepe, Pascale ^b   De Paepe, Anne ^a   Speleman, Frank ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b AZ Sint Jan Bruges   (Belgium)

Author keywords

Array CGH; Cell line; Hodgkin's lymphoma

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAT6 PROTEIN; CYLD PROTEIN, HUMAN; DNA BINDING PROTEIN; STAT6 PROTEIN, HUMAN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CHROMOSOME 15Q; CHROMOSOME 16Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA DETERMINATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HODGKIN DISEASE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LYMPHOMA CELL LINE; NODULAR SCLEROSIS HODGKIN LYMPHOMA; SUPPRESSOR GENE; THALASSEMIA MAJOR; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; DNA-BINDING PROTEINS; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HODGKIN DISEASE; HUMANS; NEOPLASM PROTEINS; STAT6 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 34548683468     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11073     Document Type: Article

References (39)

1. Küppers R, Rajewsky K. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu Rev Immunol 2002;16: 471-93.
2. Müschen M, Rajewsky K, Bräuninger A, Baur AS, Oudejans JJ, Roers A, et al. Rare occurrence of classical Hodgkin's disease as a T-cell lymphoma. J Exp Med 2000;191: 387-94.
3. Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood 2002; 99: 4283-97.
4. Krappman D, Emmerich F, Kordes U, Scharschmidt E, Dörken B, Scheidereit C. Molecular mechanisms of constitutive NF-KB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene 1999;18:943-53.
5. Mathas S, Hinz M, Anagnostopoulos I, Krapmann D, Leitz A, Jundt F, et al. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kB. EMBO 2002;21: 4104-13.
6. Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. Leuk Lymphoma 1992; 9:1-25.
7. Macleod RAF, Spitzer D, Bar-Am I, Sylvester JE, Kaufmann M, Wernich A, et al. Karyotypic dissection of Hodgkin's disease cell lines reveals ectopic subtelomeres and ribosomal DNA at sites of multiple jumping translocations and genomic amplification. Leukemia 2000;14:1803-14.
8. Joos S, Granzow M, Holtgreve-Grez H, Siebert R. Harder L, Martin-Subero J, et al. Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. Int J Cancer 2003; 103: 489-95.
9. Berglund M, Flordal E, Gullander J, Lui WO, Larsson C, Lagercrantz S, et al. Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma. Cancer Genet Cytogenet 2003;141:43-8.
10. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997;20: 399-407.
11. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z, et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 2006;66:2129-37.
12. nd edition. Cold Spring Harbor NY: Cold Spring Harbor Laboratory. 1989.
13. du Manoir S, Speicher M, Joos S, Schrock E, Popp S, Dohner H, et al. Detection of complete and partial gains and losses by comparative genomic in situ hybridization. Hum Genet 1993; 90:590-610.
14. Van Roy N, Jauch A, Van Gele M, Laureys G, Versteeg R, De Paepe A, et al. Comparative genomic hybridization analysis of numan neuroblastomas: detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines. Cancer Genet Cyotgenet 1997;92:151-4.
15. Vandesompele J, Van Roy N, Van Gele M, Laureys G, Ambros P, Heimann P, et al. Genetic heterogeneity of neuroblastoma suited by comparative genomic hybridization. Genes Chromosomes Cancer 1998;23:141-52.
16. Menten B, Pattyn F, De Preter K, Robbrecht P, Michels E, Buysse K, et al. ArrayCGHbase: an analysis platform for comparative genomic hybridization microarrays. BMC Bioinformatics 2005;6:124.
17. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004;5:557-72.
18. Pattyn F, Robbrecht P, De Paepe A, Speleman F, Vandesompele J. RTPrimerDB: the real-time PCR primer and probe database: major update. Nucleic Acid Res 2006;34 (Database issue): D684-8.
19. Van Limbergen H, Poppe B, Michaux L, Herens C, Brown J, Noens L, et al. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH. Genes Chromosomes Cancer 2002;33:60-72.
20. Matsunaga E, Chétodal E. Repulsive guidance molecule/neogenin: a novel ligand-receptor system playing multiple roles in neural development. D evelop Growth Differ 2004;46:481-6.
21. Metzger M, Conrad S, Alvarez-Bolado G, Skutella T, Just L. Gene expression of the repulsive guidance molecules during development of the mouse intestine. Dev Dyn 2005;234:169-75.
22. Woodage T, Basrai MA, Baxevanis AD, Hieter P, Collins FS. Characterization of the CHD family of proteins. Proc Natl Acad Sci USA 1997;94:11472-7.
23. Thompson PM, Gotoh T, Kok M, White PS, Brodeur GM. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. Oncogene 2003; 22:1002-11.
24. Vissers LE, Van Ravenswaaij CM, Admiraal R, Hurst JA, De Vries BB, Janssen IM, et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 2004;36:955-7.
25. Blomberg J, Darnell JE. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000;19:2468-73.
26. Kube D, Holtick U, Vockerodt M, Ahmadi T, Haier B, Behrman I, et ai. STAT3 is constitutively activated in Hodgkin cell lines. Blood 2001;98:762-70.
27. Skinnider BF, Elia AJ, Gascoyne RD, Patterson B, Trumper L, Kapp, et al. Signal transducer and activator of transcription 6 is frequendy activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2002;99: 618-26.
28. Joos S, Küpper M, Ohl S, von Bonin F, Mechtersheimer G, Bentz M, et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 2000;60:549-52.
29. Weniger MA, Melzner I, Menz CK, Wegener S, Bucur AJ, Dorsch K, et al. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phosphor-STAT5 accumulation. Oncogene 2006;25:2679-84.
30. Ohshima K, Ishiguro M, Ohgami A, Sugihara M, Seiji H, Suzumiya J, et al. Genetic analysis of sorted Hodgkin and Reed-Sternberg cells using comparative genomic hybridization. Int J Cancer 1999;82:250-5.
31. Ohshima K, Haraoka S, Yoshioka S, Kawasaki C, Tutiya T, Suzumiya J, et al. Chromosome 16q deletion and loss of E-cadherin expression in Hodgkin and Reed-Sternberg cells. Int J Cancer 2001;92:678-82.
32. Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, et al. Identification of the familial cylin-dromatosis tumour-suppressor gene. Nat Genet 2000;25:160-5.
33. Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G. The tumour suppressor CYLD negatively regulates NF-kB signalling by deubiquitination. Nature 2003;424: 801-5.
34. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-kB activation by TNFR family members. Nature 2003;424:793-6.
35. Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M, et al. Bcl10 activates the NF-kB pathway through ubiquitination of NEMO. Nature 2004; 427:167-71.
36. Joos S, Menz C, Wrobel G, Siebert R, Gesk S, Ohl S, et al. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of tne short arm of chromosome 2. Blood 2002;99: 1381-7.
37. Horie R, Watanabe T, Morishita Y, Ito K, Ishida T, Kanegae Y, et al. Ligand-independent signalling by overexpressed CD30 drives NF-kB activation m Hodgkin-Reed-Sternberg cells. Oncogene 2002;21:2493-503.
38. Gires O, Zimber-Strobl U, Gonnella R, Ueffing M, Marschall G, Zeidler R, et al. Latent membrane protein 1 of Ebstein-Barr virus mimics a constitutivefy active receptor molecule. EMBO 1997;16:6131-40.
39. Jungnickel B, Staratscheck-Jox A, Bräuninger A. Clonal deleterious mutations in the IkBα gene in the malignant cells in Hodgkin s lymphoma. J Exp Med 2000;191:395-401.